Tech Company Financing Transactions

Jennerex Biotherapeutics Funding Round

Jennerex Biotherapeutics, based in San Francisco, received $5.1 million from private investors.

Transaction Overview

Announced On
8/13/2009
Transaction Type
Venture Equity
Amount
$5,100,000
Round
Series C
Investors
Proceeds Purpose
The net proceeds of the private placement will be used to continue advancing the Company's clinical development programs with the lead product JX-594.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
450 Sansome St. 16th Floor
San Francisco, CA 94111
USA
Email Address
Overview
Jennerex Biotherapeutics, Inc. is a biotechnology company focused on the development and commercialization of first-in-class, breakthrough targeted oncolytic immunotherapy products for solid tumors.
Profile
Jennerex Biotherapeutics LinkedIn Company Profile
Social Media
Jennerex Biotherapeutics Company Twitter Account
Company News
Jennerex Biotherapeutics News
Facebook
Jennerex Biotherapeutics on Facebook
YouTube
Jennerex Biotherapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Eun-Sang Moon
  Eun-Sang Moon LinkedIn Profile  Eun-Sang Moon Twitter Account  Eun-Sang Moon News  Eun-Sang Moon on Facebook
Chief Financial Officer
Eun-Ki Min
  Eun-Ki Min LinkedIn Profile  Eun-Ki Min Twitter Account  Eun-Ki Min News  Eun-Ki Min on Facebook
Chief Operating Officer
Byung-Hak Kwak
  Byung-Hak Kwak LinkedIn Profile  Byung-Hak Kwak Twitter Account  Byung-Hak Kwak News  Byung-Hak Kwak on Facebook
Chief Technical Officer
Tae-Ho Hwang
  Tae-Ho Hwang LinkedIn Profile  Tae-Ho Hwang Twitter Account  Tae-Ho Hwang News  Tae-Ho Hwang on Facebook
VP - Operations
Georg Roth
  Georg Roth LinkedIn Profile  Georg Roth Twitter Account  Georg Roth News  Georg Roth on Facebook


 

 

Browse more venture capital transactions:

Prev: 8/13/2009: Pacific BioSciences of California venture capital transaction
Next: 8/13/2009: Crescendo Networks venture capital transaction

 

Share this article

 


Where The Data Comes From

Our team works diligently to record every notable VC transaction. All VC database entries reported here are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary